Jasper Therapeutics, Inc.·4

Jun 13, 8:45 PM ET

Tucker Edwin Jonathan 4

4 · Jasper Therapeutics, Inc. · Filed Jun 13, 2023

Insider Transaction Report

Form 4
Period: 2023-06-12
Tucker Edwin Jonathan
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-06-12+400,000400,000 total
    Exercise: $1.62Exp: 2033-06-12Voting Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to the option shall vest on June 12, 2024, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Documents

1 file
  • 4
    ownership.xmlPrimary